Seeking Alpha

Sangamo BioSciences to offer shares, stock falls

  • Sangamo BioSciences (SGMO) announces a planned public offering.
  • The size of the deal is not disclosed.
  • There will be a 15% underwriter option. (PR)
  • Shares -5.4% AH
Comments (1)
  • podell2
    , contributor
    Comments (7) | Send Message
    The way I see it, one key to success is having enough cash to get your research done and to strengthen your position negotiating with potential partners. So, I view raising cash as a positive. That said, why are their HIV studies limited to so very few patients. I'd hope they could expand the number of patients studied and advance this treatment more quickly.


    Richard Podell, MD
    18 Sep 2013, 12:21 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector